USE OF THE MULTIFUNCTIONAL TRANSCRIPTION FACTOR YINYANG-1 AND VARIANTS THEREOF FOR TREATING ILLNESSES, ESPECIALLY TYPE 1 DIABETES

Details for Australian Patent Application No. 2003300224 (hide)

Owner ERNST-MORITZ-ARNDT-UNI VERSITAT GREIFSWALD

Inventors KLOTING, Ingrid; KLOTING, Nora

Pub. Number AU-A-2003300224

PCT Number PCT/EP2003/0147

PCT Pub. Number WO2004/056857

Priority 102 61 650.7 20.12.02 DE

Filing date 19 December 2003

Wipo publication date 14 July 2004

International Classifications

C07K 014/47 Peptides having more than 20 amino acids

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 102 61 650.7 20.12.02 DE

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003300224

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003300225-ADHESIVE COMPOSITION FOR THE DIRECT JOINING OF A PRE-GELLED POLYESTER OR VINYL ESTER TO RAW RUBBER

2003300223-Collapsible frame for shelving